A 340B rebate pilot goes into effect in January for the first 10 drugs negotiated by CMS. Cash flow and administrative costs are health systems' biggest concerns.

A new influenza strain could fuel a severe flu season while a surge in measles cases threatens U.S. elimination status, emphasizing that vaccination remains critical to limiting disease spread and severity, according to faculty from Johns Hopkins Bloomberg School of Public Health.

Enrollment in Affordable Care Act health plans has soared because of enhanced subsidies enacted during the COVID-19 public health emergency. Democrats (and perhaps some moderate Republicans) want them continued. Republicans say they have better ideas about how to keep Americans in the individual market covered, including health savings accounts and association health plans.

Ophthalmologists and oncologists created a new ocular adverse event grading scale for oncology trials that addresses ambiguities and provides clear dose modification recommendations.

Addyi is the first FDA-approved treatment for low libido in women ages 65 and younger.

Dermatoscopy identifies visual features that predict melanoma metastasis risk, performing comparably to current pathology-based staging methods.

By 2020, only 10.8% of adults aged 50 and older had completed both doses of the recombinant zoster vaccine,with 14.1% receiving at least one.

A study reveals that vitiligo significantly impacts quality of life and mental health in Japanese patients, highlighting the need for early psychological support.

The biosimilar market experienced 16 new approvals by early December 2025, marking significant expansion and introducing previously unavailable biosimilar drug classes to patients.